Recent News

ASTRO 2020: Relugolix Versus Leuprolide for Localized and Recurrent Prostate Cancers

ASTRO 2020: Long-Term Follow-up With Low–Dose-Rate Prostate Brachytherapy

Prostate Cancer Prevalence in Men With Li-Fraumeni Syndrome

ASTRO 2020: Metastasis-Free Survival as Surrogate for Overall Survival in Recurrent Prostate Cancer

Is Increased Adiposity Causally Protective for Prostate Cancer?

ASTRO 2020: Using Fluciclovine PET Imaging to Guide Prostate Cancer Radiotherapy

ASTRO 2020: Hypofractionated Photon Versus Proton Therapy for Prostate Cancer

SARS-CoV-2 and Prostate Cancer: Is ADT Protective Against Infection?

Darolutamide in Treatment of Nonmetastatic Prostate Cancer: Outcomes Update From ARAMIS

Advanced Prostate Cancer: Role of Advanced Practitioners in Management

High-Risk Prostate Cancer: Three-Tiered Classification System Under Study

ESMO 2020: Talazoparib in Men With Metastatic Prostate Cancer and DNA Damage Response Alterations

Prostate Cancer and COVID-19: Delay in Time to Biopsy and Pathologic Findings

Role of ADT in Efficacy of Docetaxel in Metastatic Castration-Resistant Prostate Cancer

ESMO 2020: Adding Pembrolizumab After Enzalutamide Failure in Prostate Cancer

How Exercise May Impact Natural Killer Cells in Patients With Prostate Cancer

ESMO 2020: Survival Analysis From PROfound Trial in Metastatic Prostate Cancer

ESMO 2020: Ipatasertib Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer and COVID-19: Prioritization Strategies for Disease Management

Association Between Human Papillomaviruses and Prostate Cancer?

Prostate Cancer and COVID-19: Is Hormonal Therapy a Protective or Risk Factor?

Biologic Differences in Prostate Tumors in Men of African Ancestry: Clinical Implications

Pan-Tumor Liquid Biopsy Test Approved by FDA as Companion Diagnostic for Rucaparib

BET Bromodomain Inhibitor Plus Enzalutamide in Metastatic Prostate Cancer

Prostate Cancer and COVID-19: Does Timing of Treatment Affect Survival Outcomes?

Life Course of BMI and Risk of Aggressive Prostate Cancer

Combining Brachytherapy With Immunotherapy for High-Risk Prostate Cancer

Consensus Conference Offers Guidance on Germline Testing for Prostate Cancer

EUPROMS Study of Quality of Life in Men Treated for Prostate Cancer

Olaparib Monotherapy for Advanced Prostate Cancer With Mutations: TAPUR Update

Darolutamide Plus ADT for Nonmetastatic Prostate Cancer: Final Update From ARAMIS

Early Results With Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer

AACR COVID-19: Hormonal Therapy and Severe Virus-Related Outcomes in Prostate Cancer

Leuprolide Plus Apalutamide as Neoadjuvant Therapy for Prostate Cancer

AACR COVID-19: Recent Trends in Screening for Prostate Cancer

Updated AUA, ASTRO, and SUO Guideline for Management of Advanced Prostate Cancer

Circulating Tumor DNA Analyses in Metastatic Castration-Resistant Prostate Cancer

AACR II: Pain Management in Veterans With Metastatic Castration-Resistant Prostate Cancer

Can Findings on PSMA PET/CT Alter Management in Recurrent Prostate Cancer?

Do Men Treated With Enzalutamide for Prostate Cancer PROSPER? Final Survival Results

PDK4 Gene May Serve as Prognostic Marker in Prostate Cancer

Bipolar Androgen Therapy in Metastatic Castration-Resistant Prostate Cancer

SPARTAN Final Results on Apalutamide in Castration-Resistant Prostate Cancer

Resensitization of Prostate Cancer With Bipolar Androgen Therapy

AACR II: Is Grape Seed Extract of Benefit to Men With Prostate Cancer?

AACR II: Therapeutic Benefits of Yoga in Men Treated With Prostatectomy

Bridging the Racial Gap: Underrepresentation of Minorities in Prostate Clinical Trials

ASCO20: Genetic Profiling to Guide Targeted Screening for Prostate Cancer

ASCO20: Phase I Trial of ARV-110 for Metastatic Castration-Resistant Prostate Cancer

Targeting Metabolic Pathway in Treating Aggressive Prostate Tumors

ASCO20: Cabozantinib Plus Atezolizumab for Castration-Resistant Prostate Cancer

ASCO20: Radical Prostatectomy After ADT for High-Risk Prostate Cancer

Radiotherapies Plus Androgen Deprivation After Surgery for High-Risk Prostate Cancer

ASCO20: Novel Imaging Modality Under Study in Biochemically Recurrent Prostate Cancer

ASCO20: LuPSMA Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer

ASCO20: Predicting Outcomes in Metastatic Prostate Cancer With CTC Counts

ASCO20: HERO Trial Compares Relugolix and Leuprolide Acetate in Advanced Prostate Cancer